Mayne Pharma files damages claim against Cosette
Mayne Pharma Group (ASX:MYX) has escalated its legal dispute with Cosette Pharmaceuticals, filing a substantial damages claim in the Supreme Court of New South Wales.
Todas as matérias desta categoria, das mais recentes às mais antigas.
Mayne Pharma Group (ASX:MYX) has escalated its legal dispute with Cosette Pharmaceuticals, filing a substantial damages claim in the Supreme Court of New South Wales.
The national wage price index climbed 0.8% in the December quarter of 2025, maintaining a steady annual growth rate of 3.4%.
Magellan Financial (ASX:MFG) logged a robust operating profit after tax of $83.1 million for the first half of FY26.
Hansen Technologies (ASX:HSN) reported a total operating revenue of $191 million for the first half of FY26, representing a 7.3% increase a year earlier.
Netwealth Group (ASX:NWL) has reported a stellar start to the 2026 financial year, underpinned by a 24.7% growth in total income to $193.8 million.
Biotech firm CSL (ASX:CSL) has entered into an exclusive licensing agreement with US pharmaceutical giant Eli Lilly and Company.
Pioneer Credit (ASX:PNC) reported a statutory net profit after taxation of $10.2 million for the six months ended Dec. 31, 2025
Australian Finance Group (ASX:AFG) booked a 46% rise in net profit after tax, reaching $22.4 million for H1 FY26.
Superloop (ASX:SLC) signaled a major shift in its growth trajectory, swinging to a $5.1 million net profit for the first half of the 2026 fiscal year.
ASIC has launched a sweeping review into financial advice licensees following growing concerns over predatory lead generation tactics.
The Lottery Corporation (ASX:TLC) has reported a resilient performance for the first half of the 2026 financial year.
Energy giant Santos (ASX:STO) reported a full-year underlying net profit after tax of US$898 million, driven by sales volumes of 93.5 mmboe.
Tem um segundo para um cookie? 🍪Os cookies essenciais mantêm a Grafa funcionando bem. Alguns opcionais nos ajudam a ver o que está funcionando para melhorarmos. Você tem o controle — pode mudar de ideia quando quiser. Política de cookies · Política de privacidade